Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Prevention of Post-Operative Crohn's Recurrence
NCT00688636Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Jan 2005
- Primary completion
- Aug 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Crohn's disease comparing Infliximab with Placebo (2 arms). Primary endpoint: Proportion of Patients in Endoscopic Recurrence at One Year at 1 year. Started Jan 2005; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00688636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688636.